Cullinan Therapeutics Statistics

Total Valuation

CGEM has a market cap or net worth of $730.17 million. The enterprise value is $154.54 million.

Market Cap	730.17M
Enterprise Value	154.54M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

CGEM has 58.23 million shares outstanding. The number of shares has increased by 17.81% in one year.

Current Share Class	58.23M
Shares Outstanding	58.23M
Shares Change (YoY)	+17.81%
Shares Change (QoQ)	+5.97%
Owned by Insiders (%)	4.48%
Owned by Institutions (%)	83.61%
Float	38.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.16
P/TBV Ratio	1.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 24.46, with a Debt / Equity ratio of 0.00.

Current Ratio	24.46
Quick Ratio	23.88
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.53% and return on invested capital (ROIC) is -21.19%.

Return on Equity (ROE)	-26.53%
Return on Assets (ROA)	-20.40%
Return on Capital (ROIC)	-21.19%
Revenue Per Employee	n/a
Profits Per Employee	-$1.69M
Employee Count	85
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-14.12M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.97% in the last 52 weeks. The beta is -0.12, so CGEM's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	+44.97%
50-Day Moving Average	16.03
200-Day Moving Average	18.39
Relative Strength Index (RSI)	31.78
Average Volume (20 Days)	547,780

Short Selling Information

The latest short interest is 9.02 million, so 15.49% of the outstanding shares have been sold short.

Short Interest	9.02M
Short Previous Month	9.06M
Short % of Shares Out	15.49%
Short % of Float	23.41%
Short Ratio (days to cover)	24.87

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-187.36M
Pretax Income	-156.28M
Net Income	-143.54M
EBITDA	-187.05M
EBIT	-187.36M
Earnings Per Share (EPS)	-$2.88

Full Income Statement

Balance Sheet

The company has $578.08 million in cash and $2.45 million in debt, giving a net cash position of $575.63 million or $9.89 per share.

Cash & Cash Equivalents	578.08M
Total Debt	2.45M
Net Cash	575.63M
Net Cash Per Share	$9.89
Equity (Book Value)	627.86M
Book Value Per Share	10.80
Working Capital	567.84M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-126.81M
Capital Expenditures	n/a
Free Cash Flow	-126.81M
FCF Per Share	-$2.18

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.81%
Shareholder Yield	-17.81%
Earnings Yield	-19.66%
FCF Yield	-17.37%

Analyst Forecast

The average price target for CGEM is $31.67, which is 152.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$31.67
Price Target Difference	152.55%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.13%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2